MedTrace Logo

Precision Exercise to Improve Outcomes in Sepsis

NCT05784740 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-12-18

No results posted yet for this study

Summary

The goal of this interventional clinical research study is to assess the efficacy of a 12-week precision exercise training intervention to improve exercise tolerance in sepsis survivors.

The main question it aims to answer is does a 12-week precision exercise training program improve constant load exercise time in sepsis survivors?

Participants will:

* Answer questionnaires related to patient reported outcomes and give a blood sample
* Perform a constant load exercise test
* Complete 12-weeks (3 x per week, 36 session in total) of precision exercise training consisting of individualized, nonlinear periodized strength and aerobic exercise training.

Researchers will compare the exercise group to an attention control group of sepsis survivors who do not receive exercise training but instead undergo usual care procedures and receive general lifestyle advice 1x per week.

Conditions

Interventions

OTHER

12-week precision exercise training

The 12-week exercise intervention will consist of both aerobic and strength exercise training performed 3x per week using an individualized and nonlinear periodized approach.

Sponsors & Collaborators

  • Vancouver Coastal Health Research Institute

    collaborator OTHER

  • Simon Fraser University

    collaborator OTHER

  • St. Paul's Hospital, Canada

    collaborator OTHER

  • Providence Health & Services

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Graeme Koelwyn, PhD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-17
Primary Completion
2025-03-31
Completion
2025-08-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05784740 on ClinicalTrials.gov